| Bioactivity | 7-[4-(2-Piperidinyl)ethoxy]benzoyl Raloxifene is a liver receptor homolog-1 (LRH-1) antagonist with an IC50 of 3.1 μM[1]. | ||||||||||||
| Invitro | 7-[4-(2-Piperidinyl)ethoxy]benzoyl Raloxifene is binding to the domain (LBD) of LRH-1[1]. | ||||||||||||
| Name | 7-[4-(2-Piperidinyl)ethoxy]benzoyl Raloxifene | ||||||||||||
| CAS | 1159977-58-8 | ||||||||||||
| Formula | C42H44N2O6S | ||||||||||||
| Molar Mass | 704.87 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Rey, J., et al. Discovery of a New Class of Liver Receptor Homolog-1 (LRH-1) Antagonists: Virtual Screening, Synthesis and Biological Evaluation. ChemMedChem,2012; 7(11), 1909–1914. |